跳至主要内容
临床试验/NCT07450404
NCT07450404尚未招募不适用

PK/PD Target Attainment of Ceftriaxone for the Prevention of Early Ventilator-associated Pneumonia in Neurologically Injured Patients

Central Hospital, Nancy, France2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2026年3月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
2
主要终点
Percentage of patients with PK/PD target attainment

研究概览

简要总结

Critically ill patients admitted for acute brain injury are exposed to many heath-care associated infections such as ventilator associated pneumoniae (VAP). The PROHYVAP study, published in 2024 reported that a single dose of CEFTRIAXONE as an antibiotic prophylaxis could reduce the incidence of early VAP (VAP that occured between day 2 and day 7 of mechanical ventilation).

However, patients with acute brain injury also presented frequently augmented renal clearance (ARC), which could affect the pharmacokinetic and pharmacodynamic target attainment (PK/PD) of antibiotic prophylaxis.

This study aims to analyse the PK/PD target attainment after one dose of CEFTRIAXONE in critically ill patients with acute brain injury and to describe the effect of ARC on PK/PD target attainment during early VAP.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years or older
  • Admitted in intensive care unit for acute brain injury, including traumatic brain injury and cerebral vascular disease
  • Glasgow coma scale inferior to 12
  • Orotracheal intubation in first 12 hours of admission
  • Needed of invasive mechanical ventilation for at least 48 hours

排除标准

  • Acute brain injury related to tumoral or infectious process
  • Antibiotic therapy administered before acute brain injury for an other pathology
  • Patients with a risk of multiresistance bacteria contamination (stay in a risk area in the past 3 months, antibiotic therapy with fluoroquinolone or betalctamine in the past 3 months, hospitalization in last month before admission, documented contaminationwith multiresistance bacteria, immunodepression)
  • Patients with hish risk of death in the first 48 hours
  • Patients with a beta-lactams reported allergy

研究组 & 干预措施

Critically ill patients with acute brain injury

Patients with severe acute brain injury defined by a Glasgow coma scale < or = 8, admitted to the intensive care unit and needed invasive mechanical ventilation for at least 48 hours.

结局指标

主要结局

Percentage of patients with PK/PD target attainment

时间窗: 24 hours

Proportion of patients with serum concentrations of CEFTRIAXONE above the minimal inhibitory concentration (MIC) of 4 mg/mL (in case of undocumented VAP), or \> 4 times the MIC of documented bacteria.

次要结局

  • Impact of the PK/PD target attainment on the incidence of early ventilator associated pneumoniae(Day 7)
  • Association between augmented renal clearance and PK/PD target attainment(24 hours)
  • Association between hyperbilirubinemia and PK/PD target attainment(24 hours)
  • Association between PK/PD target attainment and day 28 mortality(Day 28)
  • Association between PK/PD target attainment and ICU length of stay(3 months)
  • Incidence of multi drug resistance bacteria(Day 28)

研究者

发起方
Central Hospital, Nancy, France
申办方类型
Other
责任方
Principal Investigator
主要研究者

STEIB Maureen

Assistante Spécialiste

Central Hospital, Nancy, France

研究点 (2)

Loading locations...

相似试验